Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 1/2 2Phase 1 1

Status

Withdrawn 1Unknown 1Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Myeloid 3

Conditions

Breast Neoplasms 44Neoplasms 43Lung Neoplasms 28Colorectal Neoplasms 21Carcinoma, Non-Small-Cell Lung 20Prostatic Neoplasms 15Ovarian Neoplasms 15Pancreatic Neoplasms 13Melanoma 11Uterine Cervical Neoplasms 10Neoplastic Cells, Circulating 9Neoplasm Metastasis 9Sarcoma 8Multiple Myeloma 8Head and Neck Neoplasms 8Glioma 8Glioblastoma 8Hematologic Neoplasms 7Colonic Neoplasms 7Carcinoma, Hepatocellular 7Lymphoma 6Leukemia, Myeloid, Acute 6Endometrial Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Gastrointestinal Neoplasms 5Disease 5Brain Neoplasms 5Urinary Bladder Neoplasms 4Rectal Neoplasms 4Peritoneal Neoplasms 4

Interventions

Cyclophosphamide 15Antilymphocyte Serum 11fludarabine phosphate 10Cyclosporine 9Busulfan 9Peripheral Blood Stem Cell Transplantation 8Mycophenolic Acid 7Filgrastim 7Methotrexate 6Whole-Body Irradiation 5Melphalan 5fludarabine 4Radiotherapy 4Methylprednisolone 4Cord Blood Stem Cell Transplantation 4Tacrolimus 3Psychiatric Rehabilitation 3Palliative Care 3Blood Specimen Collection 3sargramostim 2Thiotepa 2Therapeutics 2Stem Cell Transplantation 2Polymerase Chain Reaction 2Injections 2Granulocyte Colony-Stimulating Factor 2Dexamethasone 2Cytarabine 2Behavior Therapy 2Ascorbic Acid 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Myelodysplastic Syndromes × Blood Specimen Collection × Clear all
NCT04953312 2026-03-12

CALPRO

Assistance Publique - Hôpitaux de Paris

Phase NA Withdrawn
MyeloidOther hematologic neoplasm

COVID-19, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

NCT05983991 2025-12-26

GATA-2

Institut Claudius Regaud

Phase NA Recruiting
150 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT02489929 2015-07-03

Evaluation of Cytidine Deaminase for Patient Suffering of a Myelodysplastic Syndrom or an AML Treated by Azacytidine

Assistance Publique Hopitaux De Marseille

Phase NA Unknown
35 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myeloid, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡